Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$61,604,833
+$45,922,882 QoQ
Shares Held
8,031,921
+1.4% QoQ
Ownership
0.767%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. IBRX ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in IBRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,604,833 | 8,031,921 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,681,951 | 7,920,178 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $16,949,559 | 6,890,065 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $15,251,989 | 5,777,269 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $12,911,154 | 4,289,420 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,832,749 | 3,840,918 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,309,630 | 3,846,675 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $24,758,561 | 3,917,494 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $18,695,042 | 3,481,386 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $16,964,909 | 3,379,464 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,742,449 | 2,806,183 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,590,656 | 2,730,452 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,541,472 | 1,945,864 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,294,594 | 2,030,492 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,550,297 | 1,921,589 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,850,942 | 1,572,834 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,684,364 | 1,548,015 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,464,134 | 1,556,601 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,768,333 | 1,516,256 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $20,987,258 | 1,469,696 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $15,776,393 | 664,549 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||